XML 22 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Net income (loss) $ 723 $ 656  
(Income) loss from discontinued operations after income taxes 2 11  
Depreciation and Amortization 297 296  
Provision for (benefit from) deferred income tax (52) (122)  
Net Periodic Pension and OPEB (benefit) cost, net (3) 10  
Pension and OPEB Contributions (48) (51)  
Net (gain) loss on sales of property, businesses, consolidated companies, and investments 3 (4)  
Restructuring and asset related charges - net [1] 92 22  
Other net loss 157 75  
Accounts and notes receivable (2,810) (2,505)  
Inventories 439 379  
Accounts Payable (221) (190)  
Deferred Revenue (790) (667)  
Other Assets and Liabilities (674) (11)  
Cash Provided by (Used for) Operating Activities, Continuing Operations (2,885) (2,101)  
Cash Provided by (Used for) Operating Activities, Discontinued Operations (6) (8)  
Cash Provided by (Used for) Operating Activities (2,891) (2,109)  
Capital expenditures (81) (94)  
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested 0 8  
Investments in and loans to nonconsolidated affiliates (3) 0  
Proceeds from Sale and Maturities of Investments 8 62  
Other investing activities - net (1) (10)  
Cash provided by (used for) investing activities (77) (34)  
Net change in borrowings (less than 90 days) 521 745  
Proceeds from debt 268 637  
Payments on Debt (22) (14)  
Repurchase of Common Stock (250) (270)  
Proceeds from Exercise of Stock Options 17 35  
Dividends paid to stockholders (121) (116)  
Other financing activities, net (24) (22)  
Cash provided by (used for) financing activities 389 995  
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash Equivalents (5) 21  
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash (2,584) (1,127)  
Cash, Cash Equivalents and Restricted Cash Equivalents at Beginning of Period 4,725 3,422 $ 3,422
Cash, Cash Equivalents and Restricted Cash Equivalents at End of Period 2,141 [2] 2,295 [2] 4,725
EIDP      
Net income (loss) 723 656  
(Income) loss from discontinued operations after income taxes 2 11  
Depreciation and Amortization 297 296  
Provision for (benefit from) deferred income tax (52) (122)  
Net Periodic Pension and OPEB (benefit) cost, net (3) 10  
Pension and OPEB Contributions (48) (51)  
Net (gain) loss on sales of property, businesses, consolidated companies, and investments 3 (4)  
Restructuring and asset related charges - net 92 22  
Other net loss 157 75  
Accounts and notes receivable (2,810) (2,505)  
Inventories 439 379  
Accounts Payable (221) (190)  
Deferred Revenue (790) (667)  
Other Assets and Liabilities (674) (11)  
Cash Provided by (Used for) Operating Activities, Continuing Operations (2,885) (2,101)  
Cash Provided by (Used for) Operating Activities, Discontinued Operations (6) (8)  
Cash Provided by (Used for) Operating Activities (2,891) (2,109)  
Capital expenditures (81) (94)  
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested 0 8  
Investments in and loans to nonconsolidated affiliates (3) 0  
Proceeds from Sale and Maturities of Investments 8 62  
Other investing activities - net (1) (10)  
Cash provided by (used for) investing activities (77) (34)  
Net change in borrowings (less than 90 days) 521 745  
Net payments from (advances to) Parent on in-house banking arrangement 0 129  
Proceeds from debt 268 637  
Payments on Debt (22) (14)  
Proceeds from Exercise of Stock Options 17 35  
Other financing activities, net (24) (24)  
Cash provided by (used for) financing activities 389 995  
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash Equivalents (5) 21  
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash (2,584) (1,127)  
Cash, Cash Equivalents and Restricted Cash Equivalents at Beginning of Period 4,725 3,422 3,422
Cash, Cash Equivalents and Restricted Cash Equivalents at End of Period 2,141 2,295 $ 4,725
EIDP | Corteva [Member]      
Dividends paid to stockholders $ (371) $ (513)  
[1] Includes restructuring plans and asset related charges. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information.
[2] See Note 5 - Supplementary Information, to the interim Consolidated Financial Statements, for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.